Ovarian Cancer Canada

Western Regional Blog – BC, YK, AB, NWT and Nunavut

TRINOVA-1 Signals New Direction in Ovarian Cancer

“Adding the investigational peptibody trebananib to weekly paclitaxel prolongs the time to disease progression or death in women with recurrent, advanced ovarian cancer, the phase III TRINOVA-1 trial has shown.” IMNG Medical … Continue reading

November 19, 2013

TRINOVA-1 Signals New Direction in Ovarian Cancer

“Adding the investigational peptibody trebananib to weekly paclitaxel prolongs the time to disease progression or death in women with recurrent, advanced ovarian cancer, the phase III TRINOVA-1 trial has shown.”  … Continue reading

October 16, 2013

Complementary and Alternative Therapies

CAMEO

Research in BC

The Injustices of Ovarian Cancer

Ovarian Cancer Canada